{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:26:07Z","timestamp":1793395567257,"version":"4.5.0"},"reference-count":32,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDM"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Drug interactions necessitate careful consideration in clinical practice. It is imperative\nfor clinicians and pharmacists to monitor drug exposure and the co-administration of medications promptly\nin order to avert adverse outcomes and achieve optimal efficacy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>The prevalence of oral lesions varies from 28% to 60% in the short term after renal transplantation.\nThe clinical use of metronidazole in the treatment of anaerobic bacterial infections among solid organ\ntransplant recipients has been complicated by the potentially significant and unpredictable drug-drug interactions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We present an unexpected, clinically significant drug-drug interaction between tacrolimus and\nmetronidazole in the early period after renal transplantation and describe the potential mechanism and clinical\ncharacteristics of this drug-drug interaction through a literature review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A 34-year-old female experienced a 65% increase in dose-normalized tacrolimus trough concentration\nafter intravenous administration of metronidazole at 1000 mg\/day for 8 days. When metronidazole was\nswitched from intravenous to oral for 5 days, dose-normalized tacrolimus trough concentration was still increased\nby 52.4%. The magnitude of tacrolimus-metronidazole drug-drug interaction seems to be contingent\nupon the dose of metronidazole and the route of metronidazole administration. After cessation of metronidazole\nfor one month, this drug-drug interaction, as assessed by weight-normalized tacrolimus dose, may still persist.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>In the early period following renal transplantation, the long-term concomitant use of metronidazole\nis likely to elevate the trough concentration of tacrolimus. Gene screening for CYP3A5*3\/*3 and ABCB1\n3435C&gt;T in recipients of solid organ transplants may support individualized tacrolimus prescribing and facilitate\nthe mitigation of risks associated with drug-drug interactions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113892002364104250701091104","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T06:28:12Z","timestamp":1752560892000},"page":"153-158","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Unexpected Clinically Significant Drug-Drug Interaction between Tacrolimus and Metronidazole in the Early Period after Renal Transplantation: A Literature Review"],"prefix":"10.2174","volume":"26","author":[{"given":"Yun","family":"Xiao","sequence":"first","affiliation":[{"name":"Department of Pharmacy, The 2nd Affiliated Hospital, Jiangxi Medical College, Nanchang University, Minde Road No. 1,Nanchang, Jiangxi, 330006, China"},{"name":"Clinical Pharmacology Institute, School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang, 330006, P. R. China"},{"name":"School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, 330006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Organ Transplantation, The 2nd Affiliated Hospital, Jiangxi Medical College, NanchangUniversity, Minde Road No. 1, Nanchang, Jiangxi, 330006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The 2nd Affiliated Hospital, Jiangxi Medical College, Nanchang University, Minde Road No. 1,Nanchang, Jiangxi, 330006, China"},{"name":"Clinical Pharmacology Institute, School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang, 330006, P. R. China"},{"name":"School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, 330006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The 2nd Affiliated Hospital, Jiangxi Medical College, Nanchang University, Minde Road No. 1,Nanchang, Jiangxi, 330006, China"},{"name":"Clinical Pharmacology Institute, School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang, 330006, P. R. China"},{"name":"School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, 330006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglong","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Organ Transplantation, The 2nd Affiliated Hospital, Jiangxi Medical College, Nanchang University, Minde Road No. 1, Nanchang, Jiangxi, 330006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyao","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Organ Transplantation, The 2nd Affiliated Hospital, Jiangxi Medical College, Nanchang University, Minde Road No. 1, Nanchang, Jiangxi, 330006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Organ Transplantation, The 2nd Affiliated Hospital, Jiangxi Medical College, Nanchang University, Minde Road No. 1, Nanchang, Jiangxi, 330006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anle","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Organ Transplantation, The 2nd Affiliated Hospital, Jiangxi Medical College, Nanchang University, Minde Road No. 1, Nanchang, Jiangxi, 330006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Organ Transplantation, The 2nd Affiliated Hospital, Jiangxi Medical College, Nanchang University, Minde Road No. 1, Nanchang, Jiangxi, 330006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohui","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Organ Transplantation, The 2nd Affiliated Hospital, Jiangxi Medical College, Nanchang University, Minde Road No. 1, Nanchang, Jiangxi, 330006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuiwen","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Blood Transfusion, The 2nd Affiliated Hospital, Jiangxi Medical College; Nanchang University, Minde Road No. 1, Nanchang, Jiangxi, 330006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Organ Transplantation, The 2nd Affiliated Hospital, Jiangxi Medical College, Nanchang University, Minde Road No. 1, Nanchang, Jiangxi, 330006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Organ Transplantation, The 2nd Affiliated Hospital, Jiangxi Medical College, Nanchang University, Minde Road No. 1, Nanchang, Jiangxi, 330006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiake","family":"He","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The 2nd Affiliated Hospital, Jiangxi Medical College, Nanchang University, Minde Road No. 1,Nanchang, Jiangxi, 330006, China"},{"name":"Clinical Pharmacology Institute, School of Pharmacy, Jiangxi Medical College, NanchangUniversity, Nanchang, 330006, P. R. China"},{"name":"School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang,Jiangxi, 330006, China"},{"name":"Department of Organ Transplantation, The 2nd Affiliated Hospital, Jiangxi Medical College, NanchangUniversity, Minde Road No. 1, Nanchang, Jiangxi, 330006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41415-021-3219-1","volume":"231","author":"Didilescu A.C.","year":"2021","unstructured":"Didilescu A.C.; Vacaru R.P.; Pronk C.; Scheau C.; Lazu A.; Dan L.P.; Brand H.S.; Oral diseases after liver transplantation: A systematic review and meta-analysis. Br Dent J  2021,231(2),117-124","journal-title":"Br Dent J"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/00016357.2019.1685680","volume":"78","author":"Sarmento D.J.S.","year":"2020","unstructured":"Sarmento D.J.S.; Aires Antunes R.S.C.C.; Cristelli M.; Braz-Silva P.H.; Maciel R.; Pestana J.O.M.A.; Gallottini M.; Oral manifestations of allograft recipients immediately before and after kidney transplantation. Acta Odontol Scand  2020,78(3),217-222","journal-title":"Acta Odontol Scand"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/odi.13040","volume":"26","author":"Nunes-dos-Santos D.L.","year":"2020","unstructured":"Nunes-dos-Santos D.L.; Gomes S.V.; Rodrigues V.P.; Pereira A.L.A.; Periodontal status and clinical outcomes in kidney transplant recipients: A systematic review. Oral Dis  2020,26(1),22-34","journal-title":"Oral Dis"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41415-020-1196-4","volume":"228","author":"Didilescu A.C.","year":"2020","unstructured":"Didilescu A.C.; Lazu A.; Pronk C.; Vacaru R.P.; Brand H.S.; Clinical periodontal and dental findings in liver transplant patients: A systematic review and meta-analysis. Br Dent J  2020,228(2),108-116","journal-title":"Br Dent J"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.bjorl.2014.04.004","volume":"81","author":"Barrach R.H.","year":"2015","unstructured":"Barrach R.H.; Souza M.P.; Silva D.P.; Lopez P.S.; Montovani J.C.; Oral changes in individuals undergoing hematopoietic stem cell transplantation. Rev Bras Otorrinolaringol  2015,81(2),141-147","journal-title":"Rev Bras Otorrinolaringol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s00467-018-4030-3","volume":"34","author":"Prytu\u0142a A.","year":"2019","unstructured":"Prytu\u0142a A.; Cransberg K.; Raes A.; Drug-metabolizing enzymes CYP3A as a link between tacrolimus and vitamin D in renal transplant recipients: Is it relevant in clinical practice? Pediatr Nephrol  2019,34(7),1201-1210","journal-title":"Pediatr Nephrol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2174\/1389200219666180129151948","volume":"19","author":"Yu M.","year":"2018","unstructured":"Yu M.; Liu M.; Zhang W.; Ming Y.; Pharmacokinetics, pharmacodynamics and pharmacogenetics of tacrolimus in kidney transplantation. Curr Drug Metab  2018,19(6),513-522","journal-title":"Curr Drug Metab"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"328","DOI":"10.2165\/00003088-199223050-00002","volume":"23","author":"Lau A.H.","year":"1992","unstructured":"Lau A.H.; Lam N.P.; Piscitelli S.C.; Wilkes L.; Danziger L.H.; Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives. Clin Pharmacokinet  1992,23(5),328-364","journal-title":"Clin Pharmacokinet"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2165\/00003088-199936050-00004","volume":"36","author":"Lamp K.C.","year":"1999","unstructured":"Lamp K.C.; Freeman C.D.; Klutman N.E.; Lacy M.K.; Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials. Clin Pharmacokinet  1999,36(5),353-373","journal-title":"Clin Pharmacokinet"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/jac\/dkx351","volume":"73","author":"Dingsdag S.A.","year":"2018","unstructured":"Dingsdag S.A.; Hunter N.; Metronidazole: An update on metabolism, structure\u2013cytotoxicity and resistance mechanisms. J Antimicrob Chemother  2018,73(2),265-279","journal-title":"J Antimicrob Chemother"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1345\/aph.1H401","volume":"41","author":"Roedler R.","year":"2007","unstructured":"Roedler R.; Neuhauser M.M.; Penzak S.R.; Does metronidazole interact with CYP3A substrates by inhibiting their metabolism through this metabolic pathway? Or should other mechanisms be considered? Ann Pharmacother  2007,41(4),653-658","journal-title":"Ann Pharmacother"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/tid.12588","volume":"18","author":"Early C.R.","year":"2016","unstructured":"Early C.R.; Park J.M.; Dorsch M.P.; Pogue K.T.; Hanigan S.M.; Effect of metronidazole use on tacrolimus concentrations in transplant patients treated for lostridium difficile. Transpl Infect Dis  2016,18(5),714-720","journal-title":"Transpl Infect Dis"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1345\/aph.1E399","volume":"39","author":"Lee Page R.","year":"2005","unstructured":"Lee Page R.; Klem P.M.; Rogers C.; Potential elevation of tacrolimus trough concentrations with concomitant metronidazole therapy. Ann Pharmacother  2005,39(6),1109-1113","journal-title":"Ann Pharmacother"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"521b","DOI":"10.1093\/ndt\/14.2.521b","volume":"14","author":"Herzig K.","year":"1999","unstructured":"Herzig K.; Johnson D.W.; Marked elevation of blood cyclosporin and tacrolimus levels due to concurrent metronidazole therapy. Nephrol Dial Transplant  1999,14(2),521b-523","journal-title":"Nephrol Dial Transplant"},{"key":"ref=15","first-page":"422","volume":"3","author":"Jouret F.","year":"2010","unstructured":"Jouret F.; Sneyers B.; Goffin E.; Castanares-Zapatero D.; Interaction between tacrolimus and clindamycin. NDT Plus  [J].2010,3(4),422-424","journal-title":"NDT Plus"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/jcpt.13075","volume":"45","author":"He J.","year":"2020","unstructured":"He J.; Yu Y.; Yin C.; Liu H.; Zou H.; Ma J.; Yang W.; Liu Y.; Zhong L.; Chen X.; Clinically significant drug\u2010drug interaction between tacrolimus and fluconazole in stable renal transplant recipient and literature review. J Clin Pharm Ther  2020,45(2),264-269","journal-title":"J Clin Pharm Ther"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"jcpt.12834","DOI":"10.1111\/jcpt.12834","volume":"44","author":"Mimura A.","year":"2019","unstructured":"Mimura A.; Yamaori S.; Ikemura N.; Katsuyama Y.; Matsuzawa N.; Ohmori S.; Influence of azole antifungal drugs on blood tacrolimus levels after switching from intravenous tacrolimus to once\u2010daily modified release tacrolimus in patients receiving allogeneic hematopoietic stem cell transplantation. J Clin Pharm Ther  2019,44(4),jcpt.12834","journal-title":"J Clin Pharm Ther"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s002280000201","volume":"56","author":"Wang J.S.","year":"2000","unstructured":"Wang J.S.; Backman J.T.; Kivist\u00f6 K.T.; Neuvonen P.J.; Effects of metronidazole on midazolam metabolism in vitro and in vivo. Eur J Clin Pharmacol  2000,56(8),555-559","journal-title":"Eur J Clin Pharmacol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1592\/phco.21.15.1192.33896","volume":"21","author":"Haas C.E.","year":"2001","unstructured":"Haas C.E.; Kaufman D.C.; DiCenzo R.C.; Effects of metronidazole on hepatic CYP3A4 activity. Pharmacotherapy  2001,21(10),1192-1195","journal-title":"Pharmacotherapy"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s00228-010-0797-2","volume":"66","author":"Kim K.A.","year":"2010","unstructured":"Kim K.A.; Park J.Y.; Effect of metronidazole on the pharmacokinetics of fexofenadine, a P-glycoprotein substrate, in healthy male volunteers. Eur J Clin Pharmacol  2010,66(7),721-725","journal-title":"Eur J Clin Pharmacol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/j.2042-7158.2011.01296.x","volume":"63","author":"Tan S.Y.","year":"2011","unstructured":"Tan S.Y.; Kan E.; Lim W.Y.; Chay G.; Law J.H.K.; Soo G.W.; Bukhari N.I.; Segarra I.; Metronidazole leads to enhanced uptake of imatinib in brain, liver and kidney without affecting its plasma pharmacokinetics in mice. J Pharm Pharmacol  2011,63(7),918-925","journal-title":"J Pharm Pharmacol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1177\/0091270007308617","volume":"47","author":"Dilger K.","year":"2007","unstructured":"Dilger K.; Fux R.; R\u00f6ck D.; M\u00f6rike K.; Gleiter C.H.; Effect of high-dose metronidazole on pharmacokinetics of oral budesonide and vice versa: A double drug interaction study. J Clin Pharmacol  2007,47(12),1532-1539","journal-title":"J Clin Pharmacol"},{"key":"ref=23","first-page":"384","volume":"16","author":"Amon I.","year":"1978","unstructured":"Amon I.; Amon K.; H\u00fcller H.; Pharmacokinetics and therapeutic efficacy of metronidazole at different dosages. Int J Clin Pharmacol Biopharm  [J].1978,16(8),384-386","journal-title":"Int J Clin Pharmacol Biopharm"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/j.2042-7158.1979.tb13580.x","volume":"31","author":"Buttar H.S.","year":"1979","unstructured":"Buttar H.S.; Siddiqui W.H.; Moffatt J.H.; The disposition of [14C]metronidazole in rats following vaginal and oral administration. J Pharm Pharmacol  1979,31(1),542-544","journal-title":"J Pharm Pharmacol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1124\/dmd.124.001477","volume":"52","author":"Singh D.K.","year":"2024","unstructured":"Singh D.K.; Ahire D.; Davydov D.R.; Prasad B.; Differential tissue abundance of membrane-bound drug metabolizing enzymes and transporter proteins by global proteomics. Drug Metab Dispos  2024,52(11),1152-1160","journal-title":"Drug Metab Dispos"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/cpt.409","volume":"100","author":"Prasad B.","year":"2016","unstructured":"Prasad B.; Gaedigk A.; Vrana M.; Gaedigk R.; Leeder J.S.; Salphati L.; Chu X.; Xiao G.; Hop C.E.C.A.; Evers R.; Gan L.; Unadkat J.D.; Ontogeny of hepatic drug transporters as quantified by LC\u2010MS\/MS proteomics. Clin Pharmacol Ther  2016,100(4),362-370","journal-title":"Clin Pharmacol Ther"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/j.1540-8159.2005.09348.x","volume":"28","author":"Kounas S.P.","year":"2005","unstructured":"Kounas S.P.; Letsas K.P.; Sideris A.; Efraimidis M.; Kardaras F.; QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone. Pacing Clin Electrophysiol  2005,28(5),472-473","journal-title":"Pacing Clin Electrophysiol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1177\/106002809402801118","volume":"28","author":"Patterson B.D.","year":"1994","unstructured":"Patterson B.D.; Possible interaction between metronidazole and carbamazepine. Ann Pharmacother  1994,28(11),1303-1304","journal-title":"Ann Pharmacother"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1177\/106002809603000408","volume":"30","author":"Cooke C.E.","year":"1996","unstructured":"Cooke C.E.; Sklar G.E.; Nappi J.M.; Possible pharmacokinetic interaction with quinidine: Ciprofloxacin or metronidazole? Ann Pharmacother  1996,30(4),364-366","journal-title":"Ann Pharmacother"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1177\/106002808802200616","volume":"22","author":"Zylber-Katz E.","year":"1988","unstructured":"Zylber-Katz E.; Rubinger D.; Berlatzky Y.; Cyclosporine interactions with metronidazole and cimetidine. Drug Intell Clin Pharm  1988,22(6),504-505","journal-title":"Drug Intell Clin Pharm"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3390\/clinpract11010015","volume":"11","author":"Gnanapandithan K.","year":"2021","unstructured":"Gnanapandithan K.; Karthik N.; Gerber J.; Methadone, Metoclopramide and Metronidazole Interaction Causing Torsades de Pointes. Clin Pract  2021,11(1),101-105","journal-title":"Clin Pract"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1345\/aph.1Q087","volume":"45","author":"Gulbis A.M.","year":"2011","unstructured":"Gulbis A.M.; Culotta K.S.; Jones R.B.; Andersson B.S.; Busulfan and metronidazole: An often forgotten but significant drug interaction. Ann Pharmacother  2011,45(7-8),1024","journal-title":"Ann Pharmacother"}],"container-title":["Current Drug Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892002364104250701091104","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/243548\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892002364104250701091104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T15:14:35Z","timestamp":1768230875000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/243548\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113892002364104250701091104","relation":{},"ISSN":["1389-2002"],"issn-type":[{"value":"1389-2002","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-11-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-10","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}